Last reviewed · How we verify
The placebo of Chang 'an II Recipe
The placebo of Chang 'an II Recipe is a Small molecule drug developed by Xiyuan Hospital of China Academy of Chinese Medical Sciences. It is currently FDA-approved.
A placebo formulation with no active pharmacological mechanism.
At a glance
| Generic name | The placebo of Chang 'an II Recipe |
|---|---|
| Sponsor | Xiyuan Hospital of China Academy of Chinese Medical Sciences |
| Modality | Small molecule |
| Phase | FDA-approved |
Mechanism of action
As a placebo, this product contains no active pharmaceutical ingredients and produces therapeutic effects solely through placebo response mechanisms. It is used as a control comparator in clinical trials of the Chang'an II Recipe, a traditional Chinese medicine formulation.
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- The placebo of Chang 'an II Recipe CI brief — competitive landscape report
- The placebo of Chang 'an II Recipe updates RSS · CI watch RSS
- Xiyuan Hospital of China Academy of Chinese Medical Sciences portfolio CI